Ad
related to: pharmaceutical companies that pay dividends
Search results
Results from the WOW.Com Content Network
Let's see which companies in the pharmaceutical industry offer the most promising. Dividend payers deserve a berth in any long-term stock portfolio. But seemingly attractive dividend yields are ...
AbbVie is one of the more attractive dividend-paying stocks in the pharmaceutical industry, with a 3.6% yield at recent prices. ... can look forward to many more years of dividend growth. The ...
Investors can look forward to continued growth of Royalty Pharma's bottom line and dividend payout. Recently, the company acquired a 13.8% royalty on U.S. sales of Niktimvo, a recently approved ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Last December, Pfizer raised its dividend payout to 0.42 per share, which works out to a yield of 6.4% at recent prices. Investors who buy now can look forward to a 16th consecutive annual-payout ...
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
Dividend-paying stocks have greatly outperformed non-payers over the past 50 years or so. ... But major pharmaceutical companies tend to have a lot of drugs in development, some or many of which ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Ad
related to: pharmaceutical companies that pay dividends